David Stern Email & Phone Number

Boston, MA, US

From Lab to Launch, the AI Lab for Startups at D^3 helps Harvard academic-led innovations accelerate to have meaningful global impact. We accept only the most promising projects - teams that have deep technical expertise in their fields, commercializing new ventures born from research with AI/ML at the core of their innovation.

Freya Biosciences is a trans-Atlantic biotech company specializing in women's health. With a focus on reproductive microbial immunotherapy interventions, Freya aims to improve fertility outcomes and empower women with innovative solutions.

Lafayette, California, US

Boulder, Colorado, US

Waltham, Massachusetts, US

Provide commercialization strategy and business operational support to several well respected pharma/biotech/life science organizations/startups. Specializing in marketing strategy, managed care access differentiation, key opinion leader development, business development and strategy, clinical trial design for label claims, and market analysis.

Cambridge, Massachusetts, US

Los Angeles, CA, US

California Cryobank is the leading provider of reproductive and stem cell services in the United States. California Cryobank was sold to GI Partners in 2018. Provide strategic guidance for company on long term goals; set annual, 3 year revenue and EBITA targets.  Chair of compensation committee. Approve all executive salaries and bonus plans. Assist in.

Symbiomix Therapeutics was an Orbimed/F-Prime Capital Partners backed biopharmaceutical company that brought innovative medicines to market for prevalent gynecologic infections that can have serious health consequences. Solosec, the company's first drug was approved by the FDA as the first and only single dose treatment for bacterial vaginosis in September.

New York, NY, US

Celmatix is a privately held precision medicine company focused on maximizing lifelong female fertility. I am responsible for developing and executing the company’s go-to-market strategies for Polaris, the world's first analytics platform that helps fertility doctors create personalized treatment plans designed to maximize a woman's fertility, among other.

Head of Global Commercial, preparing to launch new innovative fertility treatment to help improve egg quality for women that have failed multiple IVF cycles or have poor egg quality.Develop global strategy and launch company’s first commercial treatment. Create launch strategy for positioning and messaging, marketing, sales, and go-to-market.

Darmstadt, Hessen, DE

Maximize long-term franchise value and ensure business sustainability. Head of Global Franchise Team comprised of Regional Business Franchise Leaders, Top 10 country Business Unit Heads (EU5, US, China, Japan, Australia, Russia), Business Development, Portfolio Management, Medical Affairs, R&D, Business Intelligence, Finance, and Manufacturing..

Boston, Massachusetts, US

Head of Commercial US Operations for Fertility, Growth Hormone, and HIV Responsible for US Commercial Operations for EMD Serono Core Product Portfolio in Reproductive Health and Metabolic Endocrinology. Full P&L responsibility, demonstrated ability to drive revenue while maintaining high margins.o Gonal-f®, Ovidrel®, Luveris®, Cetrotide®,– Reproductive.

Boston, Massachusetts, US

Responsible for the commercial operations of the Metabolic Endocrinology Business Unit in the US, Including Marketing, Medical, Sales, Business Development.

Boston, Massachusetts, US

Jersey City, NJ, US

 Create strategy and manage launch of the first Direct-To-Consumer campaign, NuvaRing. Total revenue of Therapeutic area - $350 million (2002). P&L responsibility for $58 million dollar marketing budget for Women’s Health Franchise.  Responsible for Business Development for Women’s Health Portfolio including in-license, co-marketing, and out-license.

Mba, International Marketing And Management

Ba, Biology And Economics

Education record